Skip to main content
Log in

Early onset neutropenia after mycophenolate mofetil in systemic sclerosis

  • Letter to the Editors
  • Published:
Rheumatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ciancio G, Miller J, Gonwa TA (2005) Review of major clinical trial with mycophenolate mofetil in renal transplantation. Transplantation 80 (2 Suppl):S191–S200. doi:10.1097/01.tp.0000187035.22298.ba

    Article  PubMed  CAS  Google Scholar 

  2. Kobashigawa JA, Meiser BM (2005) Review of major clinical trials with mycophenolate mofetil in cardiac transplantation. Transplantation 80 (2 Suppl):S235–S243. doi:10.1097/01.tp.0000186383.22264.b3

    Article  PubMed  CAS  Google Scholar 

  3. Chan TM, Li FK, Tang CS et al (2000) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med 343:1156–1162. doi:10.1056/NEJM200010193431604

    Article  PubMed  CAS  Google Scholar 

  4. Ginzler EM, Dooley MA, Aranow C et al (2005) Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 353:2219–2228. doi:10.1056/NEJMoa043731

    Article  PubMed  CAS  Google Scholar 

  5. Shimizu H, Takahashi M, Takeda S et al (2004) Mycophenolate mofetil prevents transplant ateriosclerosis by direct inhibition of vascular smooth muscle cell proliferation. Transplantation 77:1661–1667. doi:10.1097/01.TP.0000127592.13707.B6

    Article  PubMed  CAS  Google Scholar 

  6. Miljkovic DJ, Cvetkovic I (2003) STOSIC-GRUJICIC, TRAJKOVIC V: mycophenolate acid inhibits activation of inducible nitric oxide synthase in rodent fibroblasts. Clin Exp Immunol 132:239–246. doi:10.1046/j.1365-2249.2003.02140.x

    Article  PubMed  CAS  Google Scholar 

  7. Liossis SN, Bounas A, Andonopoulos AP (2006) Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease. Rheumatology 45:1005–1008. doi:10.1093/rheumatology/kei211

    Article  PubMed  CAS  Google Scholar 

  8. Nihtyanova SI, Brough GM, Black CM, Denton CP (2007) Mycophenolate mofetil in diffuse cutaneous systemic sclerosis—a retrospective analysis. Rheumatology 46:442–445. doi:10.1093/rheumatology/kel244

    Article  PubMed  CAS  Google Scholar 

  9. Vanthuyne M, Blockmans D, Westhovens R et al (2007) A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis. Clin Exp Rheumatol 25:287–292

    PubMed  CAS  Google Scholar 

  10. Nogueras F, Espinosa MD, Mansilia A et al (2005) Mycophenolate mofetil-induce neutropania in liver transplantation. Transplant Proc 37:1509–1511. doi:10.1016/j.transproceed.2005.02.038

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giovanna Cuomo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cuomo, G., Abignano, G. & Valentini, G. Early onset neutropenia after mycophenolate mofetil in systemic sclerosis. Rheumatol Int 29, 1529–1530 (2009). https://doi.org/10.1007/s00296-009-0879-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-009-0879-6

Keywords

Navigation